Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Scipio bioscience logo — Single-cell sequencing on every benchtop

Scipio bioscience

Single-cell sequencing on every benchtop

Founded 2017 France France 14 employees Convertible Note Total: $15.79M Biopharma, Biotechnology

General Information

Company Name Scipio bioscience
Founded Year 2017
Location France France +2
Employees 14
Industries Biopharma, Biotechnology
Funding Stage Convertible Note
Social

Get notified when Scipio bioscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Scipio bioscience

Scipio Bioscience was a biotech startup founded in 2017, headquartered in France, with a mission to enable researchers to delve into the molecular mechanisms of life for improved health and sustainability. Their flagship product, the Asteria benchtop kit, aimed to facilitate scRNA-seq sample preparation, while Cytonaut, their cloud-based data analysis software, targeted biologists and bioinformaticians. The company's focus on providing researchers with autonomy in exploring single-cell data represented a commitment to delivering high-quality results and authentic biological information. However, on 18/09/2024, Scipio Bioscience unfortunately had to cease its operations. Notably, Scipio Bioscience secured a €2.13M convertible note investment from the European Innovation Council on 28 July 2023. The company was incubated at the Paris Santé Cochin incubator, located within the Cochin Hospital in Paris. Despite its closure, the company's innovative approach to single-cell sequencing and its potential impact on disease understanding made it noteworthy in the biopharma and biotechnology industries.

Taxonomy: Sample preparation, Single-cell studies, Benchtop kits, Sequencing applications, Transcriptomics, Clinical research, Basic research, Bioinformatics, Cloud-based data analysis software

Services & Products

Asteria™ benchtop kit for easy scRNA-seq sample preparation
Cytonaut™ cloud-based data analysis software for biologists and bioinformaticians

Target Customers

academic researchers translational clinicians biologists bioinformaticians biomedical researchers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
28 Jul 2023
Grant •••••• 1
Investor
23 Mar 2022
Venture Round •••••• 1
Investor
23 Mar 2022
Series A •••••• 5
Investor Investor Investor
•••• •••• 		25 Feb 2020
Seed Round •••••• 2
Investor
•••• •••• 		14 Nov 2017

Scipio bioscience Alternatives & Competitors

Scipio bioscience vs
AC BioScience SA
AC BioScience SA Switzerland

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne.

Seed
1 employees
Biotechnology, Health and Wellness
Scipio bioscience vs
African Biosciences Ltd
African Biosciences Ltd Nigeria

Your Research Partner....

15 employees
Biotechnology
Scipio bioscience vs
Compendia Bioscience
Compendia Bioscience

Harnessing global cancer genomic data to enhance diagnostics and treatments for better patient outco...

Seed
Biotechnology

FAQ About Scipio bioscience

Single-cell sequencing on every benchtop
Scipio bioscience was founded in 2017.
Scipio bioscience is headquartered in France.
Scipio bioscience operates in the following industries: Biopharma, Biotechnology.
Scipio bioscience has approximately 14 employees.
Scipio bioscience has completed 5 funding rounds, raising a total of $15.79M. The latest funding stage is Convertible Note.
Scipio bioscience offers: Asteria™ benchtop kit for easy scRNA-seq sample preparation, Cytonaut™ cloud-based data analysis software for biologists and bioinformaticians.
Top alternatives and competitors to Scipio bioscience include AC BioScience SA, African Biosciences Ltd, Compendia Bioscience, BioScience GmbH, Ensol Biosciences Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Scipio bioscience and AC BioScience SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Scipio bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy